Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 260732, 8 pages
http://dx.doi.org/10.1155/2014/260732
Research Article

Transporter TAP1-637G and Immunoproteasome PSMB9-60H Variants Influence the Risk of Developing Vitiligo in the Saudi Population

1Department of Medical Genetics, Faculty of Medicine, Umm Al-Qura University, P.O. Box 57543, Mecca 21955, Saudi Arabia
2Department of Molecular Genetics, Medical Genetics Center, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt
3Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia
4Department of Pediatrics, Al-Qatif Central Hospital, Dammam 31911, Saudi Arabia
5Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt
6National Guard Hospitals, Faculty of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 11564, Saudi Arabia

Received 5 November 2014; Revised 20 November 2014; Accepted 21 November 2014; Published 7 December 2014

Academic Editor: Giuseppe Murdaca

Copyright © 2014 Nasser Attia Elhawary et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Nasser Attia Elhawary, Neda Bogari, Essam Hussien Jiffri, Mona Rashad, Abdulhamid Fatani, and Mohammed Tayeb, “Transporter TAP1-637G and Immunoproteasome PSMB9-60H Variants Influence the Risk of Developing Vitiligo in the Saudi Population,” Disease Markers, vol. 2014, Article ID 260732, 8 pages, 2014. https://doi.org/10.1155/2014/260732.